Global IPSC-Derived Pancreatic Beta-Like Cells Supply, Demand and Key Producers, 2026-2032
The global IPSC-Derived Pancreatic Beta-Like Cells market size is expected to reach $ 1058 million by 2032, rising at a market growth of 53.7% CAGR during the forecast period (2026-2032).
iPSC-Derived Islet ?-like Cells are insulin-secreting, ?-cell?like products generated from induced pluripotent stem cells (iPSCs) through directed differentiation, maturation induction, and quality control processes. These cells are primarily used in cell replacement therapy for type 1 diabetes, pancreatic function research, disease modeling, drug screening, and evaluation of implantation and delivery devices. Key procurement considerations include the parental iPSC line, differentiation maturity, glucose-stimulated insulin secretion capability, cellular purity, residual undifferentiated cell content, post-thaw viability, GMP compatibility, and immune protection strategies. The overall gross margin is approximately 60%.
Demand for iPSC-derived ?-like cells is driven by the shift in diabetes management from long-term glycemic control toward functional curative replacement therapies. Patients with type 1 diabetes require lifelong insulin administration, while traditional donor-derived islets are severely limited in supply. iPSCs offer scalable expansion, cell banking potential, and genetic engineering capability, making them a promising large-scale source of ? cells. As clinical data accumulate, therapeutic demand is shifting beyond demonstrating insulin secretion toward achieving long-term engraftment, stable glycemic control, and reduced reliance on immunosuppression.
Product development is focused on improving differentiation efficiency, functional maturation, cellular composition consistency, and GMP-scale manufacturing. Leading companies are advancing allogeneic universal donor cells, hypoimmunogenic gene-edited lines, encapsulation devices, and retrievable implant systems. Research-grade products are also widely used in drug screening, toxicity testing, and disease mechanism studies. Future commercialization depends not only on cell products themselves but also on supporting ecosystems such as standardized culture media, key growth factors, automated bioreactor systems, quality release testing, and cold-chain delivery infrastructure.
Regionally, North America and Europe lead in clinical translation, regulatory engagement, and financing activity, while Japan and China are highly active in iPSC foundational research and early clinical exploration. The market still faces challenges related to safety, batch consistency, cost control, immune rejection, and long-term follow-up requirements. However, once regulatory pathways become clearer, both therapeutic diabetes applications and research-grade functional cell markets are expected to significantly expand the broader supply chain opportunity space.
This report studies the global IPSC-Derived Pancreatic Beta-Like Cells demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for IPSC-Derived Pancreatic Beta-Like Cells, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of IPSC-Derived Pancreatic Beta-Like Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global IPSC-Derived Pancreatic Beta-Like Cells total market, 2021-2032, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: IPSC-Derived Pancreatic Beta-Like Cells total market, key domestic companies, and share, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells revenue by player, revenue and market share 2021-2026, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells total market by Type, CAGR, 2021-2032, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global IPSC-Derived Pancreatic Beta-Like Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, Aspect Biosystems, Evotec, Sernova, Sana Biotechnology, Century Therapeutics, Takara Bio, Cell-Easy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world IPSC-Derived Pancreatic Beta-Like Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global IPSC-Derived Pancreatic Beta-Like Cells Market, By Region:
1. How big is the global IPSC-Derived Pancreatic Beta-Like Cells market?
2. What is the demand of the global IPSC-Derived Pancreatic Beta-Like Cells market?
3. What is the year over year growth of the global IPSC-Derived Pancreatic Beta-Like Cells market?
4. What is the total value of the global IPSC-Derived Pancreatic Beta-Like Cells market?
5. Who are the Major Players in the global IPSC-Derived Pancreatic Beta-Like Cells market?
6. What are the growth factors driving the market demand?
iPSC-Derived Islet ?-like Cells are insulin-secreting, ?-cell?like products generated from induced pluripotent stem cells (iPSCs) through directed differentiation, maturation induction, and quality control processes. These cells are primarily used in cell replacement therapy for type 1 diabetes, pancreatic function research, disease modeling, drug screening, and evaluation of implantation and delivery devices. Key procurement considerations include the parental iPSC line, differentiation maturity, glucose-stimulated insulin secretion capability, cellular purity, residual undifferentiated cell content, post-thaw viability, GMP compatibility, and immune protection strategies. The overall gross margin is approximately 60%.
Demand for iPSC-derived ?-like cells is driven by the shift in diabetes management from long-term glycemic control toward functional curative replacement therapies. Patients with type 1 diabetes require lifelong insulin administration, while traditional donor-derived islets are severely limited in supply. iPSCs offer scalable expansion, cell banking potential, and genetic engineering capability, making them a promising large-scale source of ? cells. As clinical data accumulate, therapeutic demand is shifting beyond demonstrating insulin secretion toward achieving long-term engraftment, stable glycemic control, and reduced reliance on immunosuppression.
Product development is focused on improving differentiation efficiency, functional maturation, cellular composition consistency, and GMP-scale manufacturing. Leading companies are advancing allogeneic universal donor cells, hypoimmunogenic gene-edited lines, encapsulation devices, and retrievable implant systems. Research-grade products are also widely used in drug screening, toxicity testing, and disease mechanism studies. Future commercialization depends not only on cell products themselves but also on supporting ecosystems such as standardized culture media, key growth factors, automated bioreactor systems, quality release testing, and cold-chain delivery infrastructure.
Regionally, North America and Europe lead in clinical translation, regulatory engagement, and financing activity, while Japan and China are highly active in iPSC foundational research and early clinical exploration. The market still faces challenges related to safety, batch consistency, cost control, immune rejection, and long-term follow-up requirements. However, once regulatory pathways become clearer, both therapeutic diabetes applications and research-grade functional cell markets are expected to significantly expand the broader supply chain opportunity space.
This report studies the global IPSC-Derived Pancreatic Beta-Like Cells demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for IPSC-Derived Pancreatic Beta-Like Cells, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of IPSC-Derived Pancreatic Beta-Like Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global IPSC-Derived Pancreatic Beta-Like Cells total market, 2021-2032, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: IPSC-Derived Pancreatic Beta-Like Cells total market, key domestic companies, and share, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells revenue by player, revenue and market share 2021-2026, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells total market by Type, CAGR, 2021-2032, (USD Million)
Global IPSC-Derived Pancreatic Beta-Like Cells total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global IPSC-Derived Pancreatic Beta-Like Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, Aspect Biosystems, Evotec, Sernova, Sana Biotechnology, Century Therapeutics, Takara Bio, Cell-Easy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world IPSC-Derived Pancreatic Beta-Like Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global IPSC-Derived Pancreatic Beta-Like Cells Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Therapeutic Cell Products
- Research-Grade Beta-Like Cells
- Disease Model Cells
- Custom Differentiation Services
- Other Use Formats
- Allogeneic Unedited Cells
- Gene-Edited Hypoimmune Cells
- Autologous Patient-Specific Cells
- HLA-Matched Banked Cells
- Other Immune Strategies
- Pancreatic Progenitor Cells
- Immature Beta-Like Cells
- Functionally Mature Beta-Like Cells
- Islet-Like Clusters
- Mixed Endocrine Cell Preparations
- Naked Cell Suspension
- Encapsulated Cells
- Device-Loaded Cells
- Scaffold-Associated Cells
- Other Delivery Formats
- Type 1 Diabetes Cell Therapy
- Insulin-Dependent Diabetes Research
- Drug Screening and Toxicity Testing
- Disease Modeling and Mechanism Research
- Transplantation and Encapsulation Research
- Process Development and Quality Control
- Vertex Pharmaceuticals
- Aspect Biosystems
- Evotec
- Sernova
- Sana Biotechnology
- Century Therapeutics
- Takara Bio
- Cell-Easy
1. How big is the global IPSC-Derived Pancreatic Beta-Like Cells market?
2. What is the demand of the global IPSC-Derived Pancreatic Beta-Like Cells market?
3. What is the year over year growth of the global IPSC-Derived Pancreatic Beta-Like Cells market?
4. What is the total value of the global IPSC-Derived Pancreatic Beta-Like Cells market?
5. Who are the Major Players in the global IPSC-Derived Pancreatic Beta-Like Cells market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 IPSC-Derived Pancreatic Beta-Like Cells Introduction
1.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size & Forecast (2021 & 2025 & 2032)
1.3 World IPSC-Derived Pancreatic Beta-Like Cells Total Market by Region (by Headquarter Location)
1.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.3 China Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.4 Europe Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.5 Japan Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.6 South Korea Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.7 ASEAN Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.8 India Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 IPSC-Derived Pancreatic Beta-Like Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.2 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region
2.2.1 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region (2021-2026)
2.2.2 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Forecast by Region (2027-2032)
2.3 United States IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.4 China IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.5 Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.6 Japan IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.7 South Korea IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.8 ASEAN IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.9 India IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
3 WORLD IPSC-DERIVED PANCREATIC BETA-LIKE CELLS COMPANIES COMPETITIVE ANALYSIS
3.1 World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global IPSC-Derived Pancreatic Beta-Like Cells Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for IPSC-Derived Pancreatic Beta-Like Cells in 2025
3.2.3 Global Concentration Ratios (CR8) for IPSC-Derived Pancreatic Beta-Like Cells in 2025
3.3 IPSC-Derived Pancreatic Beta-Like Cells Company Evaluation Quadrant
3.4 IPSC-Derived Pancreatic Beta-Like Cells Market: Overall Company Footprint Analysis
3.4.1 IPSC-Derived Pancreatic Beta-Like Cells Market: Region Footprint
3.4.2 IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Type Footprint
3.4.3 IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Comparison
4.2.1 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based IPSC-Derived Pancreatic Beta-Like Cells Companies and Market Share, 2021-2026
4.3.1 United States Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (States, Country)
4.3.2 United States Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026)
4.4 China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue and Market Share, 2021-2026
4.4.1 China Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026)
4.5 Rest of World Based IPSC-Derived Pancreatic Beta-Like Cells Companies and Market Share, 2021-2026
4.5.1 Rest of World Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Therapeutic Cell Products
5.2.2 Research-Grade Beta-Like Cells
5.2.3 Disease Model Cells
5.2.4 Custom Differentiation Services
5.2.5 Other Use Formats
5.3 Market Segment by Type
5.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type (2021-2026)
5.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type (2027-2032)
5.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY IMMUNE STRATEGY
6.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Immune Strategy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Immune Strategy
6.2.1 Allogeneic Unedited Cells
6.2.2 Gene-Edited Hypoimmune Cells
6.2.3 Autologous Patient-Specific Cells
6.2.4 HLA-Matched Banked Cells
6.2.5 Other Immune Strategies
6.3 Market Segment by Immune Strategy
6.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy (2021-2026)
6.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy (2027-2032)
6.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Immune Strategy (2027-2032)
7 MARKET ANALYSIS BY DIFFERENTIATION MATURITY
7.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Differentiation Maturity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Differentiation Maturity
7.2.1 Pancreatic Progenitor Cells
7.2.2 Immature Beta-Like Cells
7.2.3 Functionally Mature Beta-Like Cells
7.2.4 Islet-Like Clusters
7.2.5 Mixed Endocrine Cell Preparations
7.3 Market Segment by Differentiation Maturity
7.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity (2021-2026)
7.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity (2027-2032)
7.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Differentiation Maturity (2027-2032)
8 MARKET ANALYSIS BY DELIVERY FORMAT
8.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Delivery Format: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Delivery Format
8.2.1 Naked Cell Suspension
8.2.2 Encapsulated Cells
8.2.3 Device-Loaded Cells
8.2.4 Scaffold-Associated Cells
8.2.5 Other Delivery Formats
8.3 Market Segment by Delivery Format
8.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format (2021-2026)
8.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format (2027-2032)
8.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Delivery Format (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Type 1 Diabetes Cell Therapy
9.2.2 Insulin-Dependent Diabetes Research
9.2.3 Drug Screening and Toxicity Testing
9.2.4 Disease Modeling and Mechanism Research
9.2.5 Transplantation and Encapsulation Research
9.2.6 Process Development and Quality Control
9.3 Market Segment by Application
9.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2021-2026)
9.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2027-2032)
9.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Vertex Pharmaceuticals
10.1.1 Vertex Pharmaceuticals Details
10.1.2 Vertex Pharmaceuticals Major Business
10.1.3 Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.1.4 Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Vertex Pharmaceuticals Recent Developments/Updates
10.1.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
10.2 Aspect Biosystems
10.2.1 Aspect Biosystems Details
10.2.2 Aspect Biosystems Major Business
10.2.3 Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.2.4 Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Aspect Biosystems Recent Developments/Updates
10.2.6 Aspect Biosystems Competitive Strengths & Weaknesses
10.3 Evotec
10.3.1 Evotec Details
10.3.2 Evotec Major Business
10.3.3 Evotec IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.3.4 Evotec IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Evotec Recent Developments/Updates
10.3.6 Evotec Competitive Strengths & Weaknesses
10.4 Sernova
10.4.1 Sernova Details
10.4.2 Sernova Major Business
10.4.3 Sernova IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.4.4 Sernova IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Sernova Recent Developments/Updates
10.4.6 Sernova Competitive Strengths & Weaknesses
10.5 Sana Biotechnology
10.5.1 Sana Biotechnology Details
10.5.2 Sana Biotechnology Major Business
10.5.3 Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.5.4 Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sana Biotechnology Recent Developments/Updates
10.5.6 Sana Biotechnology Competitive Strengths & Weaknesses
10.6 Century Therapeutics
10.6.1 Century Therapeutics Details
10.6.2 Century Therapeutics Major Business
10.6.3 Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.6.4 Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Century Therapeutics Recent Developments/Updates
10.6.6 Century Therapeutics Competitive Strengths & Weaknesses
10.7 Takara Bio
10.7.1 Takara Bio Details
10.7.2 Takara Bio Major Business
10.7.3 Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.7.4 Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Takara Bio Recent Developments/Updates
10.7.6 Takara Bio Competitive Strengths & Weaknesses
10.8 Cell-Easy
10.8.1 Cell-Easy Details
10.8.2 Cell-Easy Major Business
10.8.3 Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.8.4 Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Cell-Easy Recent Developments/Updates
10.8.6 Cell-Easy Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 IPSC-Derived Pancreatic Beta-Like Cells Industry Chain
11.2 IPSC-Derived Pancreatic Beta-Like Cells Upstream Analysis
11.3 IPSC-Derived Pancreatic Beta-Like Cells Midstream Analysis
11.4 IPSC-Derived Pancreatic Beta-Like Cells Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 IPSC-Derived Pancreatic Beta-Like Cells Introduction
1.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size & Forecast (2021 & 2025 & 2032)
1.3 World IPSC-Derived Pancreatic Beta-Like Cells Total Market by Region (by Headquarter Location)
1.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.3 China Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.4 Europe Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.5 Japan Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.6 South Korea Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.7 ASEAN Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.3.8 India Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 IPSC-Derived Pancreatic Beta-Like Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.2 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region
2.2.1 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region (2021-2026)
2.2.2 World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Forecast by Region (2027-2032)
2.3 United States IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.4 China IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.5 Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.6 Japan IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.7 South Korea IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.8 ASEAN IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
2.9 India IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032)
3 WORLD IPSC-DERIVED PANCREATIC BETA-LIKE CELLS COMPANIES COMPETITIVE ANALYSIS
3.1 World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global IPSC-Derived Pancreatic Beta-Like Cells Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for IPSC-Derived Pancreatic Beta-Like Cells in 2025
3.2.3 Global Concentration Ratios (CR8) for IPSC-Derived Pancreatic Beta-Like Cells in 2025
3.3 IPSC-Derived Pancreatic Beta-Like Cells Company Evaluation Quadrant
3.4 IPSC-Derived Pancreatic Beta-Like Cells Market: Overall Company Footprint Analysis
3.4.1 IPSC-Derived Pancreatic Beta-Like Cells Market: Region Footprint
3.4.2 IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Type Footprint
3.4.3 IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Comparison
4.2.1 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based IPSC-Derived Pancreatic Beta-Like Cells Companies and Market Share, 2021-2026
4.3.1 United States Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (States, Country)
4.3.2 United States Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026)
4.4 China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue and Market Share, 2021-2026
4.4.1 China Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026)
4.5 Rest of World Based IPSC-Derived Pancreatic Beta-Like Cells Companies and Market Share, 2021-2026
4.5.1 Rest of World Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Therapeutic Cell Products
5.2.2 Research-Grade Beta-Like Cells
5.2.3 Disease Model Cells
5.2.4 Custom Differentiation Services
5.2.5 Other Use Formats
5.3 Market Segment by Type
5.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type (2021-2026)
5.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type (2027-2032)
5.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY IMMUNE STRATEGY
6.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Immune Strategy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Immune Strategy
6.2.1 Allogeneic Unedited Cells
6.2.2 Gene-Edited Hypoimmune Cells
6.2.3 Autologous Patient-Specific Cells
6.2.4 HLA-Matched Banked Cells
6.2.5 Other Immune Strategies
6.3 Market Segment by Immune Strategy
6.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy (2021-2026)
6.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy (2027-2032)
6.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Immune Strategy (2027-2032)
7 MARKET ANALYSIS BY DIFFERENTIATION MATURITY
7.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Differentiation Maturity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Differentiation Maturity
7.2.1 Pancreatic Progenitor Cells
7.2.2 Immature Beta-Like Cells
7.2.3 Functionally Mature Beta-Like Cells
7.2.4 Islet-Like Clusters
7.2.5 Mixed Endocrine Cell Preparations
7.3 Market Segment by Differentiation Maturity
7.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity (2021-2026)
7.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity (2027-2032)
7.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Differentiation Maturity (2027-2032)
8 MARKET ANALYSIS BY DELIVERY FORMAT
8.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Delivery Format: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Delivery Format
8.2.1 Naked Cell Suspension
8.2.2 Encapsulated Cells
8.2.3 Device-Loaded Cells
8.2.4 Scaffold-Associated Cells
8.2.5 Other Delivery Formats
8.3 Market Segment by Delivery Format
8.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format (2021-2026)
8.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format (2027-2032)
8.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Delivery Format (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Type 1 Diabetes Cell Therapy
9.2.2 Insulin-Dependent Diabetes Research
9.2.3 Drug Screening and Toxicity Testing
9.2.4 Disease Modeling and Mechanism Research
9.2.5 Transplantation and Encapsulation Research
9.2.6 Process Development and Quality Control
9.3 Market Segment by Application
9.3.1 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2021-2026)
9.3.2 World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2027-2032)
9.3.3 World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Vertex Pharmaceuticals
10.1.1 Vertex Pharmaceuticals Details
10.1.2 Vertex Pharmaceuticals Major Business
10.1.3 Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.1.4 Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Vertex Pharmaceuticals Recent Developments/Updates
10.1.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
10.2 Aspect Biosystems
10.2.1 Aspect Biosystems Details
10.2.2 Aspect Biosystems Major Business
10.2.3 Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.2.4 Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Aspect Biosystems Recent Developments/Updates
10.2.6 Aspect Biosystems Competitive Strengths & Weaknesses
10.3 Evotec
10.3.1 Evotec Details
10.3.2 Evotec Major Business
10.3.3 Evotec IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.3.4 Evotec IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Evotec Recent Developments/Updates
10.3.6 Evotec Competitive Strengths & Weaknesses
10.4 Sernova
10.4.1 Sernova Details
10.4.2 Sernova Major Business
10.4.3 Sernova IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.4.4 Sernova IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Sernova Recent Developments/Updates
10.4.6 Sernova Competitive Strengths & Weaknesses
10.5 Sana Biotechnology
10.5.1 Sana Biotechnology Details
10.5.2 Sana Biotechnology Major Business
10.5.3 Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.5.4 Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sana Biotechnology Recent Developments/Updates
10.5.6 Sana Biotechnology Competitive Strengths & Weaknesses
10.6 Century Therapeutics
10.6.1 Century Therapeutics Details
10.6.2 Century Therapeutics Major Business
10.6.3 Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.6.4 Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Century Therapeutics Recent Developments/Updates
10.6.6 Century Therapeutics Competitive Strengths & Weaknesses
10.7 Takara Bio
10.7.1 Takara Bio Details
10.7.2 Takara Bio Major Business
10.7.3 Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.7.4 Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Takara Bio Recent Developments/Updates
10.7.6 Takara Bio Competitive Strengths & Weaknesses
10.8 Cell-Easy
10.8.1 Cell-Easy Details
10.8.2 Cell-Easy Major Business
10.8.3 Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Product and Services
10.8.4 Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Cell-Easy Recent Developments/Updates
10.8.6 Cell-Easy Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 IPSC-Derived Pancreatic Beta-Like Cells Industry Chain
11.2 IPSC-Derived Pancreatic Beta-Like Cells Upstream Analysis
11.3 IPSC-Derived Pancreatic Beta-Like Cells Midstream Analysis
11.4 IPSC-Derived Pancreatic Beta-Like Cells Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key IPSC-Derived Pancreatic Beta-Like Cells Players in 2025
Table 12. World IPSC-Derived Pancreatic Beta-Like Cells Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global IPSC-Derived Pancreatic Beta-Like Cells Company Evaluation Quadrant
Table 14. Head Office of Key IPSC-Derived Pancreatic Beta-Like Cells Players
Table 15. IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Type Footprint
Table 16. IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Application Footprint
Table 17. IPSC-Derived Pancreatic Beta-Like Cells Mergers & Acquisitions Activity
Table 18. United States VS China IPSC-Derived Pancreatic Beta-Like Cells Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (States, Country)
Table 21. United States Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share (2021-2026)
Table 23. China Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (Province, Country)
Table 24. China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share (2021-2026)
Table 26. Rest of World Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share (2021-2026)
Table 29. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type (2027-2032) & (USD Million)
Table 32. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy, (USD Million), 2021 & 2025 & 2032
Table 33. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Immune Strategy (2021-2026) & (USD Million)
Table 34. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy (2027-2032) & (USD Million)
Table 35. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity, (USD Million), 2021 & 2025 & 2032
Table 36. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Differentiation Maturity (2021-2026) & (USD Million)
Table 37. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity (2027-2032) & (USD Million)
Table 38. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 39. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Delivery Format (2021-2026) & (USD Million)
Table 40. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format (2027-2032) & (USD Million)
Table 41. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2021-2026) & (USD Million)
Table 43. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2027-2032) & (USD Million)
Table 44. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 45. Vertex Pharmaceuticals Major Business
Table 46. Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 47. Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Vertex Pharmaceuticals Recent Developments/Updates
Table 49. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
Table 50. Aspect Biosystems Basic Information, Manufacturing Base and Competitors
Table 51. Aspect Biosystems Major Business
Table 52. Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 53. Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Aspect Biosystems Recent Developments/Updates
Table 55. Aspect Biosystems Competitive Strengths & Weaknesses
Table 56. Evotec Basic Information, Manufacturing Base and Competitors
Table 57. Evotec Major Business
Table 58. Evotec IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 59. Evotec IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Evotec Recent Developments/Updates
Table 61. Evotec Competitive Strengths & Weaknesses
Table 62. Sernova Basic Information, Manufacturing Base and Competitors
Table 63. Sernova Major Business
Table 64. Sernova IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 65. Sernova IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Sernova Recent Developments/Updates
Table 67. Sernova Competitive Strengths & Weaknesses
Table 68. Sana Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Sana Biotechnology Major Business
Table 70. Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 71. Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sana Biotechnology Recent Developments/Updates
Table 73. Sana Biotechnology Competitive Strengths & Weaknesses
Table 74. Century Therapeutics Basic Information, Manufacturing Base and Competitors
Table 75. Century Therapeutics Major Business
Table 76. Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 77. Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Century Therapeutics Recent Developments/Updates
Table 79. Century Therapeutics Competitive Strengths & Weaknesses
Table 80. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 81. Takara Bio Major Business
Table 82. Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 83. Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Takara Bio Recent Developments/Updates
Table 85. Takara Bio Competitive Strengths & Weaknesses
Table 86. Cell-Easy Basic Information, Manufacturing Base and Competitors
Table 87. Cell-Easy Major Business
Table 88. Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 89. Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Cell-Easy Recent Developments/Updates
Table 91. Cell-Easy Competitive Strengths & Weaknesses
Table 92. Global Key Players of IPSC-Derived Pancreatic Beta-Like Cells Upstream (Raw Materials)
Table 93. Global IPSC-Derived Pancreatic Beta-Like Cells Typical Customers
Table 1. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key IPSC-Derived Pancreatic Beta-Like Cells Players in 2025
Table 12. World IPSC-Derived Pancreatic Beta-Like Cells Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global IPSC-Derived Pancreatic Beta-Like Cells Company Evaluation Quadrant
Table 14. Head Office of Key IPSC-Derived Pancreatic Beta-Like Cells Players
Table 15. IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Type Footprint
Table 16. IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Application Footprint
Table 17. IPSC-Derived Pancreatic Beta-Like Cells Mergers & Acquisitions Activity
Table 18. United States VS China IPSC-Derived Pancreatic Beta-Like Cells Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (States, Country)
Table 21. United States Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share (2021-2026)
Table 23. China Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (Province, Country)
Table 24. China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share (2021-2026)
Table 26. Rest of World Based IPSC-Derived Pancreatic Beta-Like Cells Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share (2021-2026)
Table 29. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type (2027-2032) & (USD Million)
Table 32. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy, (USD Million), 2021 & 2025 & 2032
Table 33. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Immune Strategy (2021-2026) & (USD Million)
Table 34. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy (2027-2032) & (USD Million)
Table 35. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity, (USD Million), 2021 & 2025 & 2032
Table 36. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Differentiation Maturity (2021-2026) & (USD Million)
Table 37. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity (2027-2032) & (USD Million)
Table 38. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 39. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Value by Delivery Format (2021-2026) & (USD Million)
Table 40. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format (2027-2032) & (USD Million)
Table 41. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2021-2026) & (USD Million)
Table 43. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2027-2032) & (USD Million)
Table 44. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 45. Vertex Pharmaceuticals Major Business
Table 46. Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 47. Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Vertex Pharmaceuticals Recent Developments/Updates
Table 49. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
Table 50. Aspect Biosystems Basic Information, Manufacturing Base and Competitors
Table 51. Aspect Biosystems Major Business
Table 52. Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 53. Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Aspect Biosystems Recent Developments/Updates
Table 55. Aspect Biosystems Competitive Strengths & Weaknesses
Table 56. Evotec Basic Information, Manufacturing Base and Competitors
Table 57. Evotec Major Business
Table 58. Evotec IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 59. Evotec IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Evotec Recent Developments/Updates
Table 61. Evotec Competitive Strengths & Weaknesses
Table 62. Sernova Basic Information, Manufacturing Base and Competitors
Table 63. Sernova Major Business
Table 64. Sernova IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 65. Sernova IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Sernova Recent Developments/Updates
Table 67. Sernova Competitive Strengths & Weaknesses
Table 68. Sana Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Sana Biotechnology Major Business
Table 70. Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 71. Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sana Biotechnology Recent Developments/Updates
Table 73. Sana Biotechnology Competitive Strengths & Weaknesses
Table 74. Century Therapeutics Basic Information, Manufacturing Base and Competitors
Table 75. Century Therapeutics Major Business
Table 76. Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 77. Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Century Therapeutics Recent Developments/Updates
Table 79. Century Therapeutics Competitive Strengths & Weaknesses
Table 80. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 81. Takara Bio Major Business
Table 82. Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 83. Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Takara Bio Recent Developments/Updates
Table 85. Takara Bio Competitive Strengths & Weaknesses
Table 86. Cell-Easy Basic Information, Manufacturing Base and Competitors
Table 87. Cell-Easy Major Business
Table 88. Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Product and Services
Table 89. Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Cell-Easy Recent Developments/Updates
Table 91. Cell-Easy Competitive Strengths & Weaknesses
Table 92. Global Key Players of IPSC-Derived Pancreatic Beta-Like Cells Upstream (Raw Materials)
Table 93. Global IPSC-Derived Pancreatic Beta-Like Cells Typical Customers
LIST OF FIGURES
Figure 1. IPSC-Derived Pancreatic Beta-Like Cells Picture
Figure 2. World IPSC-Derived Pancreatic Beta-Like Cells Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World IPSC-Derived Pancreatic Beta-Like Cells Total Revenue (2021-2032) & (USD Million)
Figure 4. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 13. IPSC-Derived Pancreatic Beta-Like Cells Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 16. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Region (2021-2032)
Figure 17. United States IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 18. China IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 23. India IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of IPSC-Derived Pancreatic Beta-Like Cells by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for IPSC-Derived Pancreatic Beta-Like Cells Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for IPSC-Derived Pancreatic Beta-Like Cells Markets in 2025
Figure 27. United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Type in 2025
Figure 31. Therapeutic Cell Products
Figure 32. Research-Grade Beta-Like Cells
Figure 33. Disease Model Cells
Figure 34. Custom Differentiation Services
Figure 35. Other Use Formats
Figure 36. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Type (2021-2032)
Figure 37. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy, (USD Million), 2021 & 2025 & 2032
Figure 38. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Immune Strategy in 2025
Figure 39. Allogeneic Unedited Cells
Figure 40. Gene-Edited Hypoimmune Cells
Figure 41. Autologous Patient-Specific Cells
Figure 42. HLA-Matched Banked Cells
Figure 43. Other Immune Strategies
Figure 44. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Immune Strategy (2021-2032)
Figure 45. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity, (USD Million), 2021 & 2025 & 2032
Figure 46. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Differentiation Maturity in 2025
Figure 47. Pancreatic Progenitor Cells
Figure 48. Immature Beta-Like Cells
Figure 49. Functionally Mature Beta-Like Cells
Figure 50. Islet-Like Clusters
Figure 51. Mixed Endocrine Cell Preparations
Figure 52. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Differentiation Maturity (2021-2032)
Figure 53. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 54. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Delivery Format in 2025
Figure 55. Naked Cell Suspension
Figure 56. Encapsulated Cells
Figure 57. Device-Loaded Cells
Figure 58. Scaffold-Associated Cells
Figure 59. Other Delivery Formats
Figure 60. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Delivery Format (2021-2032)
Figure 61. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Application in 2025
Figure 63. Type 1 Diabetes Cell Therapy
Figure 64. Insulin-Dependent Diabetes Research
Figure 65. Drug Screening and Toxicity Testing
Figure 66. Disease Modeling and Mechanism Research
Figure 67. Transplantation and Encapsulation Research
Figure 68. Process Development and Quality Control
Figure 69. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Application (2021-2032)
Figure 70. IPSC-Derived Pancreatic Beta-Like Cells Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. IPSC-Derived Pancreatic Beta-Like Cells Picture
Figure 2. World IPSC-Derived Pancreatic Beta-Like Cells Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World IPSC-Derived Pancreatic Beta-Like Cells Total Revenue (2021-2032) & (USD Million)
Figure 4. World IPSC-Derived Pancreatic Beta-Like Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company IPSC-Derived Pancreatic Beta-Like Cells Revenue (2021-2032) & (USD Million)
Figure 13. IPSC-Derived Pancreatic Beta-Like Cells Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 16. World IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Region (2021-2032)
Figure 17. United States IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 18. China IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 23. India IPSC-Derived Pancreatic Beta-Like Cells Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of IPSC-Derived Pancreatic Beta-Like Cells by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for IPSC-Derived Pancreatic Beta-Like Cells Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for IPSC-Derived Pancreatic Beta-Like Cells Markets in 2025
Figure 27. United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Type in 2025
Figure 31. Therapeutic Cell Products
Figure 32. Research-Grade Beta-Like Cells
Figure 33. Disease Model Cells
Figure 34. Custom Differentiation Services
Figure 35. Other Use Formats
Figure 36. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Type (2021-2032)
Figure 37. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy, (USD Million), 2021 & 2025 & 2032
Figure 38. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Immune Strategy in 2025
Figure 39. Allogeneic Unedited Cells
Figure 40. Gene-Edited Hypoimmune Cells
Figure 41. Autologous Patient-Specific Cells
Figure 42. HLA-Matched Banked Cells
Figure 43. Other Immune Strategies
Figure 44. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Immune Strategy (2021-2032)
Figure 45. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity, (USD Million), 2021 & 2025 & 2032
Figure 46. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Differentiation Maturity in 2025
Figure 47. Pancreatic Progenitor Cells
Figure 48. Immature Beta-Like Cells
Figure 49. Functionally Mature Beta-Like Cells
Figure 50. Islet-Like Clusters
Figure 51. Mixed Endocrine Cell Preparations
Figure 52. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Differentiation Maturity (2021-2032)
Figure 53. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 54. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Delivery Format in 2025
Figure 55. Naked Cell Suspension
Figure 56. Encapsulated Cells
Figure 57. Device-Loaded Cells
Figure 58. Scaffold-Associated Cells
Figure 59. Other Delivery Formats
Figure 60. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Delivery Format (2021-2032)
Figure 61. World IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Application in 2025
Figure 63. Type 1 Diabetes Cell Therapy
Figure 64. Insulin-Dependent Diabetes Research
Figure 65. Drug Screening and Toxicity Testing
Figure 66. Disease Modeling and Mechanism Research
Figure 67. Transplantation and Encapsulation Research
Figure 68. Process Development and Quality Control
Figure 69. World IPSC-Derived Pancreatic Beta-Like Cells Market Size Market Share by Application (2021-2032)
Figure 70. IPSC-Derived Pancreatic Beta-Like Cells Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
